To say the Hep C space is crowded would be an understatement.
The HCV space is crowded but it is not unduly crowded, IMO. There is no other serious and common medical condition where the business opportunity is as compelling for a major advance in the standard of care during the next 5-10 years.
Market Data 
Markets 
AI
